查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1937094

全球熱療癌症治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Hyperthermia Cancer Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計熱療癌症治療市場將從 2025 年的 2.5016 億美元成長到 2034 年的 4.4958 億美元，2026 年至 2034 年的複合年成長率為 6.73%。

受熱療作為癌症輔助性治療的認知度不斷提高的推動，熱療癌症治療市場預計將顯著成長。隨著研究不斷證實熱療能夠增強放射線治療和化療的效果，醫療機構正擴大將這種治療方法納入其治療通訊協定中。全球癌症發生率的上升，以及對創新微創治療方法日益成長的需求，正在推動市場成長。此外，聚焦超音波和射頻消融等技術的進步也提高了熱療的精準性和有效性。

治療方法和監測技術的創新正在塑造熱療癌症治療市場的未來前景。先進加熱設備和技術的開發提高了靶向腫瘤的能力，同時最大限度地減少了對周圍健康組織的損傷。此外，MRI 和電腦斷層掃描等影像技術的整合使得在治療過程中即時監測溫度變化成為可能，從而確保最佳的治療效果。隨著研究不斷探索熱療與其他癌症療法的協同作用，預計市場將出現更多能夠提高整體療效的聯合治療通訊協定。

此外，隨著製藥公司和學術機構認知到熱療在癌症治療中的潛力，加大對臨床研發的投入將對熱療癌症治療市場產生正面影響。腫瘤學家、研究人員和技術開發人員之間的合作對於推進臨床試驗和確保熱療的成功應用至關重要。在這種不斷變化的環境下，監管機構有望簡化創新熱療設備和治療方法的核准流程，使癌症患者能夠更快地獲得有效的治療方案。未來的重點將日益轉向將熱療融入綜合癌症治療策略，強調個人化治療方案和多學科協作在改善患者預後的重要性。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球熱療癌症治療市場：依設備類型分類

  • 市場分析、洞察與預測
  • 微波熱療裝置
  • 超音波熱療裝置
  • 紅外線熱療設備
  • 短波熱療裝置

第5章：全球熱療癌症治療市場：依應用分類

  • 市場分析、洞察與預測
  • 乳癌
  • 肝癌
  • 軟組織肉瘤
  • 頭頸部腫瘤
  • 攝護腺癌

第6章 全球熱療癌症治療市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 診所
  • 研究機構
  • 癌症中心

第7章 全球熱療癌症治療市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • CION Cancer Clinics
    • Combat Medical Ltd
    • First Baptist Medical Center
    • Haifu Medical Technology Co. Ltd
    • HCG Oncology
    • Hyperthermia Cancer Institute
    • Loyola Medicine
    • Novavida Integrative Medical Center
    • Pyrexar Medical
    • RanD Biotech SpA
    • Siteman Cancer Center
    • Sona Nanotech Inc
    • Verthermia
    • Zhongshan Hospital
簡介目錄
Product Code: VMR11215080

The Hyperthermia Cancer Treatment Market size is expected to reach USD 449.58 Million in 2034 from USD 250.16 Million (2025) growing at a CAGR of 6.73% during 2026-2034.

The hyperthermia cancer treatment market is poised for significant growth, driven by the increasing recognition of hyperthermia as a complementary therapy in cancer treatment. As research continues to demonstrate the efficacy of hyperthermia in enhancing the effectiveness of radiation and chemotherapy, healthcare providers are increasingly incorporating this modality into treatment protocols. The rising prevalence of cancer globally, coupled with the demand for innovative and less invasive treatment options, is propelling the market forward. Additionally, advancements in technology, such as focused ultrasound and radiofrequency ablation, are enhancing the precision and effectiveness of hyperthermia treatments.

Innovations in treatment delivery and monitoring are shaping the future of the hyperthermia cancer treatment market. The development of advanced heating devices and techniques is improving the ability to target tumors while minimizing damage to surrounding healthy tissues. Furthermore, the integration of imaging technologies, such as MRI and CT scans, is enabling real-time monitoring of temperature changes during treatment, ensuring optimal therapeutic outcomes. As research continues to explore the synergistic effects of hyperthermia with other cancer therapies, the market is likely to witness the introduction of combination treatment protocols that enhance overall efficacy.

Moreover, the hyperthermia cancer treatment market will benefit from increased investment in clinical research and development, as pharmaceutical companies and academic institutions recognize the potential of hyperthermia in cancer care. Collaborative efforts between oncologists, researchers, and technology developers will be essential in advancing clinical trials and ensuring the successful implementation of hyperthermia treatments. As the landscape evolves, regulatory bodies are expected to streamline approval processes for innovative hyperthermia devices and therapies, facilitating faster access to effective treatment options for cancer patients. The focus will increasingly shift towards integrating hyperthermia into comprehensive cancer care strategies, emphasizing the importance of personalized treatment plans and multidisciplinary approaches in improving patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

  • Microwave Hyperthermia Device
  • Ultrasound Hyperthermia Device
  • Infrared Hyperthermia Device
  • Short-wave Hyperthermia Device

By Application

  • Breast Cancer
  • Liver Cancer
  • Short Tissue Sarcoma
  • Head & Neck Tumor
  • Prostate Cancer

By End-User

  • Hospitals
  • Clinics
  • Research Institutes
  • Cancer Centers

COMPANIES PROFILED

  • CION Cancer Clinics, Combat Medical Ltd, First Baptist Medical Center, Haifu Medical Technology Co Ltd, HCG Oncology, Hyperthermia Cancer Institute, Loyola Medicine, Novavida Integrative Medical Center, Pyrexar Medical, RanD Biotech SpA, Siteman Cancer Center, Sona Nanotech Inc, Verthermia, Zhongshan Hospital

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Device Type
  • 4.2. Microwave Hyperthermia Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Ultrasound Hyperthermia Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Infrared Hyperthermia Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Short-wave Hyperthermia Device Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Liver Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Short Tissue Sarcoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Head & Neck Tumor Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Cancer Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Device Type
    • 7.2.2 By Application
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Device Type
    • 7.3.2 By Application
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Device Type
    • 7.4.2 By Application
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Device Type
    • 7.5.2 By Application
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Device Type
    • 7.6.2 By Application
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HYPERTHERMIA CANCER TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 CION Cancer Clinics
    • 9.2.2 Combat Medical Ltd
    • 9.2.3 First Baptist Medical Center
    • 9.2.4 Haifu Medical Technology Co. Ltd
    • 9.2.5 HCG Oncology
    • 9.2.6 Hyperthermia Cancer Institute
    • 9.2.7 Loyola Medicine
    • 9.2.8 Novavida Integrative Medical Center
    • 9.2.9 Pyrexar Medical
    • 9.2.10 RanD Biotech SpA
    • 9.2.11 Siteman Cancer Center
    • 9.2.12 Sona Nanotech Inc
    • 9.2.13 Verthermia
    • 9.2.14 Zhongshan Hospital